185 related articles for article (PubMed ID: 27534788)
21. [F-18 fluorodeoxyglucose positron emission tomography in malignant lymphoma].
Mikosch P
Wien Med Wochenschr; 2002; 152(11-12):269-75. PubMed ID: 12138654
[TBL] [Abstract][Full Text] [Related]
22. Non-Small Cell Lung Cancer with Estrogen Receptors and ALK Positivity.
Žarnayová L; Kolek V; Bouchal J; Ehrmann J
Klin Onkol; 2018; 31(6):457-460. PubMed ID: 31035769
[TBL] [Abstract][Full Text] [Related]
23. [Staging of non-Hodgkin's lymphoma--recommendations of the Czech Lymphoma Study Group].
Sýkorová A; Belada D; Smolej L; Pytlík R; Benesová K; Vásová I; Papajík T; Sálek D; Procházka V; Matuska M; Brejcha M; Kubácková K; Kabícková E; Móciková H; Campr V; Trnený M;
Klin Onkol; 2010; 23(3):146-54. PubMed ID: 20608324
[TBL] [Abstract][Full Text] [Related]
24. [The Influence of Palliative Chemotherapy on the Quality of Life of Patients with Gastric Cancer].
Šmíd D; Skalický T; Fichtl J; Kubačková D; Doležal J; Novák P; Svoboda T; Slouka D
Klin Onkol; 2016; 29(4):279-86. PubMed ID: 27534785
[TBL] [Abstract][Full Text] [Related]
25. [Computerized tomography and F-18-FDG positron emission tomography in staging of malignant lymphomas: a comparison].
Bumann D; de Wit M; Beyer W; Beese M; Lübeck M; Bücheler E; Clausen M
Rofo; 1998 May; 168(5):457-65. PubMed ID: 9617362
[TBL] [Abstract][Full Text] [Related]
26. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
Chavdarova LI; Tzonevska AD; Piperkova EN
Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584
[TBL] [Abstract][Full Text] [Related]
27. Stereotactic Body Radiotherapy - Current Indications.
Burkoň P; Slavik M; Kazda T; Pospíšil P; Prochazka T; Vrzal M; Šlampa P
Klin Onkol; 2019; 32(1):10-24. PubMed ID: 30894002
[TBL] [Abstract][Full Text] [Related]
28. Criteria-Based Imaging and Response Evaluation of Lymphoma 20 Years After Cheson: What is New?
Skusa C; Weber MA; Böttcher S; Thierfelder KM
Rofo; 2020 Jul; 192(7):657-668. PubMed ID: 32215902
[TBL] [Abstract][Full Text] [Related]
29. FDG-PET/CT in the management of lymphomas: current status and future directions.
El-Galaly TC; Villa D; Gormsen LC; Baech J; Lo A; Cheah CY
J Intern Med; 2018 Oct; 284(4):358-376. PubMed ID: 29989234
[TBL] [Abstract][Full Text] [Related]
30. The utility of FDG-PET for managing patients with malignant lymphoma: analysis of data from a single cancer center.
Imataki O; Tamai Y; Yokoe K; Furukawa T; Kawakami K
Intern Med; 2009; 48(17):1509-13. PubMed ID: 19721294
[TBL] [Abstract][Full Text] [Related]
31. Initial staging of lymphoma with positron emission tomography and computed tomography.
Hicks RJ; Mac Manus MP; Seymour JF
Semin Nucl Med; 2005 Jul; 35(3):165-75. PubMed ID: 16098290
[TBL] [Abstract][Full Text] [Related]
32. Use of Fludarabine for the Treatment of Indolent Lymphoma with Chylothorax.
Wild A; Holasová J; Králiková E
Klin Onkol; 2018; 31(4):301-304. PubMed ID: 30541315
[TBL] [Abstract][Full Text] [Related]
33. TNM staging system may be superior to Lugano and Ann Arbor systems in predicting the overall survival of patients with primary gastrointestinal lymphoma.
Chang S; Shi X; Xu Z; Liu Q
J BUON; 2015; 20(3):812-9. PubMed ID: 26214635
[TBL] [Abstract][Full Text] [Related]
34. The role of FDG-PET imaging in the management of lymphoma.
Kostakoglu L; Leonard JP; Coleman M; Goldsmith SJ
Clin Adv Hematol Oncol; 2004 Feb; 2(2):115-21. PubMed ID: 16163171
[TBL] [Abstract][Full Text] [Related]
35. Inter-Observer Agreement of Whole-Body Computed Tomography in Staging and Response Assessment in Lymphoma: The Lugano Classification.
Razek AAKA; Shamaa S; Lattif MA; Yousef HH
Pol J Radiol; 2017; 82():441-447. PubMed ID: 29662570
[TBL] [Abstract][Full Text] [Related]
36. Multicenter Comparison of Contrast-Enhanced FDG PET/CT and 64-Slice Multi-Detector-Row CT for Initial Staging and Response Evaluation at the End of Treatment in Patients With Lymphoma.
Gómez León N; Delgado-Bolton RC; Del Campo Del Val L; Cabezas B; Arranz R; García M; Cannata J; González Ortega S; Pérez Sáez MÁ; López-Botet B; Rodríguez-Vigil B; Mateo M; Colletti PM; Rubello D; Carreras JL
Clin Nucl Med; 2017 Aug; 42(8):595-602. PubMed ID: 28604477
[TBL] [Abstract][Full Text] [Related]
37. [Magnetic resonance imaging in the staging of malignant lymphomas].
Mikhaĭlov AI; Tiurin IE; Panov VO
Vestn Rentgenol Radiol; 2014; (2):60-7. PubMed ID: 25272725
[TBL] [Abstract][Full Text] [Related]
38. [Values of Different Evaluation Criteria of Interim
Zhu LT; Cen XN; Ou JP; Qiu ZX; Wang LH; Liu W; Wang WS; Dong YJ; Liang ZY; Wang MJ; Xu WL; Sun YH; Wang Q; Yin Y; Ren HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):431-437. PubMed ID: 28446288
[TBL] [Abstract][Full Text] [Related]
39. Molecular Classification of Medullobastomas by Whole Genome Expression Profiling.
Nosková H; Adamcová S; Knoflíčková LDR; Pavelka Z; Vejmělková K; Zitterbart K; Slabý O; Štěrba J
Klin Onkol; 2019; 32(Supplementum1):171-173. PubMed ID: 31064192
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
